Brexit will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.

The hard work for the UK govt is yet to come, given the EU withdrawal talks and the trading relationship negotiations that the UK has yet to embark on with the EU.

The local industry is stressing any positives, including development of the govt’s new Life Sciences Strategy, part of the overall UK Industrial Strategy. This should offer manufacturers much support.

In this podcast, Association of British Healthcare Industries' (ABHI) chief operating officer Nishan Sunthares, and director of healthcare policy Richard Phillips, set the scene for Brexit, describe the current realities and air their thoughts about the potential opportunities that could emerge from a situation that few had thought likely.